Back

Apolipoprotein and inflammatory biomarker changes following marked triglyceride reduction with the GalNAc-conjugated APOC3 siRNA RBD5044

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Emerging lipid-lowering therapeutic modalities Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Sofia Nilsson

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

5 More presentations in this session

Presentation thumbnail
RNA targeted therapies for lipoprotein(a) lowering: systematic review and meta analysis of siRNA and antisense oligonucleotides
Doctor B. Buot (Quezon City, PH)
Abstract
Presentation thumbnail
Dose-related effects of olezarsen in hypertriglyceridaemia: a systematic review and meta-analysis of 2,610 patients
Miss S. Martinez-Topete (Tijuana, MX)
Abstract
Presentation thumbnail
Comparative effectiveness of probucol versus ezetimibe in statin-treated patients with established atherosclerotic cardiovascular disease
Doctor L. Liu (Tianjin, CN)
Abstract
Presentation thumbnail
Design and baseline data of AZURE-HeFH, a phase 3 study assessing the effect of the oral PCSK9 inhibitor laroprovstat on LDL cholesterol in patients with heterozygous familial hypercholesterolaemia
Doctor E. Stroes (Amsterdam, NL)
Abstract
Presentation thumbnail
Evolocumab early reduces Interleukin-1β/Interleukin-17A and improves left ventricular function in ST-segment elevation myocardial infarction: an observational study in the real world
Professor J. Gao (Tianjin, CN)
Abstract

Access the full session

Session thumbnail
Emerging lipid-lowering therapeutic modalities

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Congress Presentation
Cardiovascular and inflammatory biomarkers in cancer patients and their impact on mortality
1 September 2019
thumbnail
Congress Presentation
Exploring the mediating role of inflammation in the link between urinary copper and dyslipidemia
4 April 2025
thumbnail
Congress Presentation
Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK biobank
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources